The role of targeted therapy in the management of high-risk resected kidney cancer: What have we learned and how will it inform future adjuvant trials

Landon C. Brown, Tian Zhang, Daniel J. George

Research output: Contribution to journalReview articlepeer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'The role of targeted therapy in the management of high-risk resected kidney cancer: What have we learned and how will it inform future adjuvant trials'. Together they form a unique fingerprint.

Medicine & Life Sciences